DK3505157T3 - Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression - Google Patents

Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression Download PDF

Info

Publication number
DK3505157T3
DK3505157T3 DK17461651.6T DK17461651T DK3505157T3 DK 3505157 T3 DK3505157 T3 DK 3505157T3 DK 17461651 T DK17461651 T DK 17461651T DK 3505157 T3 DK3505157 T3 DK 3505157T3
Authority
DK
Denmark
Prior art keywords
ketamin
treatment
composition
dry powder
resistant depression
Prior art date
Application number
DK17461651.6T
Other languages
English (en)
Inventor
Maciej Wieczorek
Ewa Tratkiewicz
Przemyslaw Perko
Original Assignee
Celon Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celon Pharma Sa filed Critical Celon Pharma Sa
Application granted granted Critical
Publication of DK3505157T3 publication Critical patent/DK3505157T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
DK17461651.6T 2017-12-29 2017-12-29 Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression DK3505157T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17461651.6A EP3505157B1 (en) 2017-12-29 2017-12-29 Dry powder ketamine composition for pulmonary administration in treatment-resistant depression

Publications (1)

Publication Number Publication Date
DK3505157T3 true DK3505157T3 (da) 2022-02-28

Family

ID=60915417

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17461651.6T DK3505157T3 (da) 2017-12-29 2017-12-29 Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression
DK18773471.0T DK3731815T3 (da) 2017-12-29 2018-09-28 Tørpulver-ketaminsammensætning til anvendelse i behandlingen af depression via pulmonal indgivelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK18773471.0T DK3731815T3 (da) 2017-12-29 2018-09-28 Tørpulver-ketaminsammensætning til anvendelse i behandlingen af depression via pulmonal indgivelse

Country Status (16)

Country Link
US (1) US20200337999A1 (da)
EP (2) EP3505157B1 (da)
JP (1) JP7315556B2 (da)
KR (1) KR20200105857A (da)
CN (1) CN111818912A (da)
AU (1) AU2018395791A1 (da)
BR (1) BR112020013282A2 (da)
CA (1) CA3087090A1 (da)
DK (2) DK3505157T3 (da)
EA (1) EA202091618A1 (da)
ES (2) ES2907692T3 (da)
HU (2) HUE058320T2 (da)
MX (1) MX2020006900A (da)
PL (2) PL3505157T3 (da)
PT (2) PT3505157T (da)
WO (1) WO2019129397A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3628313A1 (en) * 2018-09-28 2020-04-01 Celon Pharma S.A. Ketamine composition for use in a method of treatment of depression by pulmonary administration

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69629108T2 (de) * 1995-02-24 2004-04-22 Weg, Stuart L. Anwendung von ketamin zur entgiftung
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
EP1567145B1 (en) * 2002-11-18 2009-06-03 Yaupon Therapeutics, Inc. Analgesic uses of (s)-norketamine
GB0523031D0 (en) * 2005-11-11 2005-12-21 Yaupon Therapeutics Enhancement of morphine analgesia by s(-)-norketamine
KR20090029690A (ko) 2006-03-22 2009-03-23 마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 우울증을 치료하기 위한 케타민의 투여 방법
DE102007009888A1 (de) 2007-02-28 2008-09-04 Hermann, Holger Lars, Dr. Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
US20130236573A1 (en) * 2012-03-12 2013-09-12 Janssen Pharmaceutica Nv Esketamine for the treatment of treatment-refractory or treatment-resistant depression
US20140079740A1 (en) 2012-08-02 2014-03-20 ClinPharm Support GmbH Oral transmucosal adminstration forms of s-ketamine
KR20210028278A (ko) 2013-03-15 2021-03-11 얀센 파마슈티카 엔.브이. S-케타민 하이드로클로라이드의 약제학적 조성물
EP3636251B1 (en) 2013-03-15 2022-01-19 Janssen Pharmaceutica NV Pharmaceutical composition of s-ketamine hydrochloride
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
EP3628313A1 (en) * 2018-09-28 2020-04-01 Celon Pharma S.A. Ketamine composition for use in a method of treatment of depression by pulmonary administration

Also Published As

Publication number Publication date
US20200337999A1 (en) 2020-10-29
KR20200105857A (ko) 2020-09-09
CN111818912A (zh) 2020-10-23
JP7315556B2 (ja) 2023-07-26
EP3731815B1 (en) 2021-12-08
BR112020013282A2 (pt) 2020-12-01
HUE058320T2 (hu) 2022-07-28
EA202091618A1 (ru) 2021-03-17
HUE058099T2 (hu) 2022-07-28
EP3505157B1 (en) 2021-12-08
EP3505157A1 (en) 2019-07-03
CA3087090A1 (en) 2019-07-04
PT3731815T (pt) 2022-02-15
JP2021510682A (ja) 2021-04-30
PL3505157T3 (pl) 2022-04-11
ES2907692T3 (es) 2022-04-26
WO2019129397A1 (en) 2019-07-04
DK3731815T3 (da) 2022-02-28
AU2018395791A1 (en) 2020-07-16
PT3505157T (pt) 2022-02-18
MX2020006900A (es) 2020-11-09
EP3731815A1 (en) 2020-11-04
ES2907781T3 (es) 2022-04-26
PL3731815T3 (pl) 2022-04-11

Similar Documents

Publication Publication Date Title
DK3496739T3 (da) Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension
DK3149019T3 (da) Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
MA45779A (fr) Polypeptides immunomdulateurs et compositions et procédés associés
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3307262T3 (da) Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
DK3925607T3 (da) Farmaceutiske sammensætninger til behandlingen af cystisk fibrosetransmembrankonduktansregulator-medierede sygdomme
DK3185957T3 (da) Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3658132T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af mitokondrielle dysfunktion-relaterede sygdomme
DK3445451T3 (da) Sammensætninger og fremgangsmåder til behandling af lysosomale lagringssygdomme og sygdomme kendetegnet ved lysosomal dysfunktion
DK3318251T3 (da) Sammensætning til forebyggelse eller behandling af fedme eller lipidrelateret metabolisk sygdom
ES2841649T5 (es) Composición farmacéutica
DK3288640T3 (da) Tørshampoosammensætning
DK3138600T3 (da) Tørpulverinhalator
DK3270890T3 (da) Cyclosporin-formuleringer til anvendelse ved forebyggelse eller behandling af kronisk afstødning af lungetransplantat
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
BR112016024667A2 (pt) composições de revestimento melhorado e processos para fabricação das mesmas
DK3423533T3 (da) Sammensætning til multifunktionel gulvbehandling
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
DK3773615T3 (da) Flydende sammensætning til anvendelse ved behandling af slimhinden i munden-svælget-struben-spiserøret
DK3197556T3 (da) Sammensætning til forebyggelse og/eller behandling af allergisymptomer
DK3436073T3 (da) Sammensætning omfattende PIC til behandling af cancer
DK3505157T3 (da) Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression
DK3490970T3 (da) Sammensætninger til behandling af lungefibrose
DK3359185T3 (da) Antitumoral sammensætning